Publications by authors named "David Kleinberg"

Claim this Profile
T
The posterior nasoseptal flap: A novel technique for closure after endoscopic transsphenoidal resection of pituitary adenomas.
James Barger, Matthew Siow, Michael Kader, Katherine Phillips, Girish Fatterpekar, David Kleinberg

Surg Neurol Int· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly.
Rudolf Fahlbusch, David Kleinberg, Beverly Biller, Vivien Bonert, Michael Buchfelder

Pituitary· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of low dose versus high dose human growth hormone on body composition and lipids in adults with GH deficiency: a meta-analysis of placebo-controlled randomized trials.
Connie B Newman, John D Carmichael, David L Kleinberg

Pituitary· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial.
Shlomo Melmed, Vera Popovic, Martin Bidlingmaier, Moises Mercado, Aart Jan van der Lely, David Kleinberg

J Clin Endocrinol Metab· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial.
Baljit Singh, Julia A Smith, Deborah M Axelrod, Pietro Ameri, Heather Levitt, David L Kleinberg

Breast Cancer Res· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acromegaly: assessing the disorder and navigating therapeutic options for treatment.
Shlomo Melmed, David L Kleinberg, Vivien Bonert, Maria Fleseriu

Endocr Pract· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A panoramic view of the skull base: systematic review of open and endoscopic endonasal approaches to four tumors.
Christopher S Graffeo, August R Dietrich, Bartosz Grobelny, Meng Zhang, Judith D Goldberg, David Kleinberg

Pituitary· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study.
Stephan Petersenn, Andrew J Farrall, Christophe De Block, Shlomo Melmed, Jochen Schopohl, David Kleinberg

Pituitary· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus document: A consensus on the medical treatment of acromegaly.
Andrea Giustina, Philippe Chanson, David Kleinberg, Marcello D Bronstein, David R Clemmons

Nat Rev Endocrinol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth hormone should be used only for approved indications.
David R Clemmons, Mark Molitch, Andrew R Hoffman, Anne Klibanski, Christian J Strasburger, David L Kleinberg

J Clin Endocrinol Metab· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients.
Mark L Hartman, Rong Xu, Brenda J Crowe, Leslie L Robison, Eva Marie Erfurth, David L Kleinberg

J Clin Endocrinol Metab· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative approach to insulin-like growth factor-1 inhibition for treatment of breast cancer.
Pietro Ameri, Ann Danoff, David L Kleinberg

J Clin Oncol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pivotal role of insulin-like growth factor I in normal mammary development.
David L Kleinberg, Mary Helen Barcellos-Hoff

Endocrinol Metab Clin North Am· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia.
David L Kleinberg, Pietro Ameri, Baljit Singh

Pituitary· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.
Shlomo Melmed, Felipe F Casanueva, Andrew R Hoffman, David L Kleinberg, Victor M Montori

J Clin Endocrinol Metab· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moderate doses of hGH (0.64 mg/d) improve lipids but not cardiovascular function in GH-deficient adults with normal baseline cardiac function.
Connie B Newman, Katalin A Frisch, Barry Rosenzweig, Ronenn Roubenoff, Mariano Rey, David L Kleinberg

J Clin Endocrinol Metab· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement.
Andrea F Attanasio, Daojun Mo, Eva Marie Erfurth, Meng Tan, Ken Y Ho, David Kleinberg

J Clin Endocrinol Metab· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.
David L Kleinberg, Teresa L Wood, Priscilla A Furth, Adrian V Lee

Endocr Rev· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGF-I, GH, and sex steroid effects in normal mammary gland development.
David L Kleinberg, Weifeng Ruan

J Mammary Gland Biol Neoplasia· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study.
Annamaria Colao, Roger Abs, David González Bárcena, Philippe Chanson, Wolfgang Paulus, David L Kleinberg

Clin Endocrinol (Oxf)· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like growth factor (IGF)-I controls prostate fibromuscular development: IGF-I inhibition prevents both fibromuscular and glandular development in eugonadal mice.
David L Kleinberg, Weifeng Ruan, Douglas Yee, Kalman T Kovacs, Sergio Vidal

Endocrinology· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90.
John D Carmichael, Ann Danoff, Daniela Milani, Ronenn Roubenoff, Martin L Lesser, David L Kleinberg

Clin Endocrinol (Oxf)· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.
Felipe F Casanueva, Mark E Molitch, Janet A Schlechte, Roger Abs, Vivien Bonert, David Kleinberg

Clin Endocrinol (Oxf)· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3?
Weifeng Ruan, Fabian Fahlbusch, David R Clemmons, Marie E Monaco, Paul D Walden, David L Kleinberg

Mol Endocrinol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly.
Shlomo Melmed, Richard Sternberg, David Cook, Anne Klibanski, Philippe Chanson, David Kleinberg

J Clin Endocrinol Metab· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis